Lab Automation Market Set for Robust Growth to USD 18.39 Billion by 2033, Led by North America's 48.6% Market Share | Key Players - Thermo Fisher Scientific, Tecan Group, Siemens Healthineers

Leander Texas -

The global Lab Automation Market size was estimated at USD 8.27 billion in 2024 and is projected to reach USD 18.39 billion by 2033, growing at a CAGR of 9.3% from 2025 to 2033.

The lab automation market's robust growth is driven by key developments in the United States, such as HighRes Biosolutions' acquisition of Let's Go Robotics to expand its automation portfolio, and strong R&D investment in AI-driven platforms, while in Japan, increased collaborations like ABB Robotics and METTLER TOLEDO advancing lab automation integration are boosting efficiency and adoption.

Download your exclusive sample report today: (corporate email gets priority access):https://www.datamintelligence.com/download-sample/lab-automation-market?prtk

Key Industry Development-

United States: Key Industry Developments
✅ December 2025: Thermo Fisher Scientific launched the Aurora Lab Automation Suite, integrating AI-driven robotics for high-throughput sample processing, reducing manual errors by 40% and boosting workflow efficiency in U.S. biopharma labs.
​
✅ November 2025: Agilent Technologies introduced an upgraded liquid handling system with cloud-connected LIMS integration, enabling real-time data analytics for faster drug discovery pipelines across major U.S. research institutions.
​
✅ October 2025: Beckman Coulter debuted the Biomek Echo One automated workstation, featuring modular microfluidics for precise PCR and NGS prep, targeting high-volume clinical labs amid rising diagnostic demands.

Asia Pacific / Japan: Key Industry Developments
✅ November 2025: Shimadzu Corporation released the Nexera XR AI-enhanced HPLC automation platform in Japan, optimizing lab-on-a-chip workflows for pharmaceutical R&D with 25% faster analysis times.
​
✅ September 2025: Hitachi High-Tech unveiled a collaborative robot (cobot) system for lab automation, integrating with ELNs for seamless sample tracking, supporting Japan's push toward smart manufacturing in biotech.
​
✅ August 2025: Tecan Japan launched the Fluent BioStack workstation, emphasizing modular robotics for high-throughput screening, aligning with regional investments in precision medicine and automated diagnostics.

Strategic Mergers and Acquisitions:

In December 2025, Tecan Group AG completed the acquisition of certain assets from Wako Automation, including its flagship DirectorTM scheduling software and select hardware modules, as part of its strategy to expand robotic workcell and laboratory automation capabilities worldwide; the transaction was finalized on December 1, 2025, strengthening Tecan's end-to-end automation solutions and software integration in complex workflows.

Earlier in July 2025, Waters Corporation agreed to merge with the Biosciences & Diagnostic Solutions business of Becton, Dickinson and Company in a Reverse Morris Trust transaction valued at approximately USD 17.5 billion; announced on July 14, 2025, the merger is designed to create a larger life-science and diagnostics leader with expanded analytical and diagnostic offerings, expected to close in early 2026 and nearly double Waters' addressable market in chromatography, mass spectrometry, and diagnostic solutions.

In April 2025, Brookfield Asset Management agreed to acquire Antylia Scientific from private-equity partner GTCR for USD 1.4 billion, marking one of the year's largest lab equipment platform deals; announced on April 2, 2025, this transaction underlines strong private-equity interest in lab tools and analytical solutions, with Antylia's portfolio spanning over 200,000 products used in lab automation, diagnostics, and environmental analysis.

Major Players:-
Thermo Fisher Scientific | Tecan Group | Siemens Healthineers | Roche Holding AG | QIAGEN N.V. | PerkinElmer Inc. | Hamilton Robotics | Agilent Technologies | Beckman Coulter Inc.

• Thermo Fisher Scientific
Thermo Fisher Scientific leads the lab automation market through its broad portfolio of robotic liquid handlers, integrated workflow solutions, and advanced analytical instruments. Its strong global distribution network, continuous acquisitions, and focus on genomics and biopharma automation strengthen its market dominance across research, clinical, and pharmaceutical laboratories.

• Tecan Group
Tecan Group is a pioneer in automated liquid handling and laboratory robotics. The company's customizable platforms, strong OEM partnerships, and innovation in life science instrumentation support pharmaceutical and diagnostic applications. Its emphasis on precision, scalability, and digital integration positions it as a global automation technology leader.

• Siemens Healthineers
Siemens Healthineers leads through advanced diagnostic automation systems and integrated laboratory solutions. Its track automation platforms streamline clinical workflows, reduce human error, and enhance throughput. Strong presence in hospital diagnostics and continuous R&D investment in AI-driven laboratory technologies reinforce its leadership in clinical lab automation worldwide.

• Roche Holding AG
Roche Holding AG drives market leadership with fully automated diagnostic systems and molecular testing platforms. Its strong footprint in clinical diagnostics, personalized medicine, and high-throughput laboratory systems supports hospitals and reference labs. Strategic investments in digital diagnostics and integrated automation enhance operational efficiency and accuracy.

• Agilent Technologies
Agilent Technologies leads through advanced laboratory automation instruments, chromatography systems, and software-driven workflow solutions. Its focus on precision analytics, pharmaceutical quality control, and biotechnology research strengthens its competitive edge. Continuous innovation, strong global service capabilities, and automation integration strategies sustain its market leadership position.

"Secure your 30% discount - get this report before the offer expires."
:https://www.datamintelligence.com/buy-now-page?report=lab-automation-market?prtk (Purchase 2 or more Repots and get 50% Discount)

Market Segmenatation-

1. Segmentation by Automation Type

In the United States, laboratory automation is typically segmented into total automation systems and modular automation systems, with total automation widely adopted in large clinical and pharmaceutical labs to streamline workflows, improve consistency, and reduce analyst workload, while modular systems are preferred in flexible research settings where customizable solutions are required. The Japanese market similarly distinguishes between whole-lab automation and modular automation solutions, with hospitals and advanced research facilities increasingly investing in fully integrated automated systems to boost throughput and minimize manual errors amid rising healthcare demands.

2. Segmentation by Product/Equipment Type

For the US market, key product segments include automated workstations, robotic systems, liquid handling equipment, and software platforms, with automated workstations and liquid handling solutions contributing significantly to revenue due to strong clinical chemistry and biotech research activity. In Japan, the product segmentation also covers workstations, robotic systems, liquid handling units, and laboratory management software, and the adoption of high-precision robotic and liquid handling systems is expanding, especially in diagnostic labs and pharmaceutical R&D centres seeking to address labor shortages and improve analytical throughput.

3. Segmentation by End-Use/Application

In the United States, the lab automation market is segmented by major end users such as clinical laboratories, research institutions, biotechnology and pharmaceutical companies, and these sectors represent strong demand drivers with clinical diagnostics and drug discovery often accounting for the largest share. In Japan, end user segmentation includes pharmaceutical and biotech firms, hospitals and clinical diagnostic centres, and academic research institutions, where automation adoption is growing rapidly to support aging population needs, clinical diagnostics efficiency, and advanced life sciences research.

4. Segmentation by Process or Function

Within the US laboratory automation landscape, segmenting by process includes continuous flow and discrete processing, each offering efficiencies for different laboratory workflows; continuous processing often dominates because it supports high-volume sample handling in clinical and industrial labs. Meanwhile in Japan, segmentation by laboratory function-such as sample preparation, data analysis, testing, and reporting-reflects the market's emphasis on integrating complex automated processes that reduce human intervention and enhance reliability in both clinical and research workflows.

Market Drivers:-

• Expansion of Biopharmaceutical R&D Investments (US & Japan): In the US, funding from the National Institutes of Health exceeded USD 45 billion in recent fiscal allocations, accelerating demand for automated liquid handling and high-throughput screening systems. In Japan, support from the Japan Agency for Medical Research and Development is strengthening robotics adoption in regenerative medicine and drug discovery labs.

• Rising Adoption of Robotics and AI-Enabled Laboratories: US-based automation providers such as Thermo Fisher Scientific are integrating AI-driven sample preparation and data analytics platforms to improve reproducibility. In Japan, laboratory robotics innovation led by Yaskawa Electric Corporation is supporting precision-driven automated workflows across academic and pharmaceutical laboratories.

• Growing Clinical Diagnostic Testing Volumes: Increasing molecular and genomic testing in US hospital networks is driving deployment of automated analyzers to manage higher sample throughput. In Japan, the expansion of advanced diagnostic labs supported by Sysmex Corporation is reinforcing demand for fully integrated hematology and clinical lab automation systems.

• Labor Shortages and Operational Efficiency Pressures: The US clinical laboratory workforce shortage is accelerating replacement of manual processes with automated sample handling and tracking systems. Similarly, Japan's aging workforce and productivity reforms are prompting hospitals and research institutes to deploy automation platforms to maintain accuracy while reducing dependency on manual technicians.

• Strategic Partnerships and Smart Lab Initiatives: In the US, collaborations between pharmaceutical firms and automation providers such as Danaher Corporation are advancing modular lab automation ecosystems. In Japan, smart laboratory initiatives aligned with Ministry of Economy, Trade and Industry digital transformation programs are accelerating implementation of connected and fully automated research facilities.

Regional insights:-

North America: 48.6% (largest share, led by the United States dominating adoption in pharmaceutical R&D, clinical diagnostics, and biotechnology) - North America holds the largest share of the global lab automation market, with the U.S. contributing a substantial portion of that regional dominance.

U.S. Specific: The U.S. alone represents the majority of North America's share and over 40% of global demand as per IMARC Group and others - driven by federal research investment and large integrated clinical labs.

Asia Pacific: 26% (rapid growth supported largely by healthcare infrastructure expansion and biotechnology investment across China, Japan, and India) - Asia Pacific is a significant market and often fastest growing region in forecasts.

Japan Specific: Japan accounts for roughly 7% of the global lab automation market, reflecting strong precision workflows and an aging population emphasizing automated diagnostics.

Europe: 28% (steady share fueled by structured laboratory modernization, strong pharmaceutical bases, and regulatory compliance) - Europe typically places behind North America and on par with or slightly above Asia Pacific.

Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/lab-automation-market?prtk

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?pratik
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insightsthrough pricing analysis, market share breakdowns, and competitive intelligence. Thecompany specializes in strategic reports that guide businesses in high-growth sectors suchas nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter,LinkedIn and Facebook.

This release was published on openPR.